Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Personalized Diabetes Medicine Program, |
RCV000664114 | SCV000787566 | likely benign | Monogenic diabetes | 2017-09-01 | criteria provided, single submitter | research | ACMG Criteria:PP3 (7 predictors), BP4 (3 predictors), BS2 (5 cases and 5 controls in T2DM) |
Labcorp Genetics |
RCV002060805 | SCV002388270 | likely benign | not provided | 2023-10-28 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV002467981 | SCV002764439 | uncertain significance | Maturity-onset diabetes of the young type 9; Type 2 diabetes mellitus | 2021-10-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235333 | SCV003934780 | likely benign | not specified | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003938017 | SCV004755369 | likely benign | PAX4-related disorder | 2022-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |